3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Astrocytoma
1
Adenocarcinoma
1
Abdominal Cancer
1
Interventions
Tadalafil
1
Influenza Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Abdominal Cancer
×
Tadalafil
×
Clear all
NCT02998736
2022-12-28
PERIOP-04
Ottawa Hospital Research Institute
Phase 1
Completed
28 enrolled